1 EXHIBIT 10.30 THESE SECURITIES HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, TOGETHER WITH THE REGULATIONS PROMULGATED THEREUNDER (THE "SECURITIES ACT"), AND MAY NOT BE SOLD, OFFERED FOR SALE, TRANSFERRED, PLEDGED OR IN THE...Sciclone Pharmaceuticals Inc • November 17th, 1998 • Pharmaceutical preparations • California
Company FiledNovember 17th, 1998 Industry Jurisdiction
1 EXHIBIT 4.4 CONFIDENTIAL TREATMENT - EDITED COPY OPTION AGREEMENTOption Agreement • March 29th, 2001 • Sciclone Pharmaceuticals Inc • Pharmaceutical preparations • New York
Contract Type FiledMarch 29th, 2001 Company Industry Jurisdiction
RECITALSRights Agreement • July 28th, 2003 • Sciclone Pharmaceuticals Inc • Pharmaceutical preparations
Contract Type FiledJuly 28th, 2003 Company Industry
2 3 (b) This Warrant may not be exercised as to fractional shares of Common Stock. In the event that the exercise of this Warrant, in full or in part, would result in the issuance of any fractional share of Common Stock, then in such event Warrant...Sciclone Pharmaceuticals Inc • July 23rd, 1998 • Pharmaceutical preparations • New York
Company FiledJuly 23rd, 1998 Industry Jurisdiction
Exhibit 4.4Registration Rights Agreement • April 2nd, 1998 • Sciclone Pharmaceuticals Inc • Pharmaceutical preparations • New York
Contract Type FiledApril 2nd, 1998 Company Industry Jurisdiction
ARTICLE ICommon Stock Purchase Agreement • March 26th, 2003 • Sciclone Pharmaceuticals Inc • Pharmaceutical preparations • California
Contract Type FiledMarch 26th, 2003 Company Industry Jurisdiction
ARTICLE 1 DEFINITIONSSupply Agreement • April 20th, 2000 • Sciclone Pharmaceuticals Inc • Pharmaceutical preparations
Contract Type FiledApril 20th, 2000 Company Industry
1 2 CONFIDENTIAL TREATMENT--EDITED COPYSciclone Pharmaceuticals Inc • May 15th, 2001 • Pharmaceutical preparations
Company FiledMay 15th, 2001 Industry
RECITALSIndemnity Agreement • October 31st, 2003 • Sciclone Pharmaceuticals Inc • Pharmaceutical preparations • Delaware
Contract Type FiledOctober 31st, 2003 Company Industry Jurisdiction
ANDRights Agreement • October 14th, 1997 • Sciclone Pharmaceuticals Inc • Pharmaceutical preparations • Delaware
Contract Type FiledOctober 14th, 1997 Company Industry Jurisdiction
RECITALSAcquisition Agreement • April 30th, 1999 • Sciclone Pharmaceuticals Inc • Pharmaceutical preparations • California
Contract Type FiledApril 30th, 1999 Company Industry Jurisdiction
SIGNATURE PAGE TO SECOND AMENDMENT OF EMPLOYMENT AGREEMENT]Employment Agreement • March 29th, 2001 • Sciclone Pharmaceuticals Inc • Pharmaceutical preparations
Contract Type FiledMarch 29th, 2001 Company Industry
1 EXHIBIT 10.2 CONFIDENTIAL TREATMENT--EDITED COPY MATERIALS TRANSFER AGREEMENT This Agreement, made as of December 21, 2000, is by and between SciClone Pharmaceuticals, Inc. ("SciClone"), having a principal place of business at 901 Mariners Island...Confidential Treatment • May 15th, 2001 • Sciclone Pharmaceuticals Inc • Pharmaceutical preparations
Contract Type FiledMay 15th, 2001 Company Industry
1 EXHIBIT 10.3 REGISTRATION RIGHTS AGREEMENT THIS REGISTRATION RIGHTS AGREEMENT (this "Rights Agreement"), entered into as of June 30, 1998, between Cheyenne LLC (the "Investor"), and SciClone Pharmaceuticals, Inc., a California corporation (the...Registration Rights Agreement • July 23rd, 1998 • Sciclone Pharmaceuticals Inc • Pharmaceutical preparations • New York
Contract Type FiledJuly 23rd, 1998 Company Industry Jurisdiction
1 EXHIBIT 10.4 CONFIDENTIAL TREATMENT REQUESTED -- EDITED COPY REGISTRATION RIGHTS AGREEMENT REGISTRATION RIGHTS AGREEMENT, dated as of October 26, 2000, by and between SciClone Pharmaceuticals, Inc., a California corporation (the "Company"), and UBS...Registration Rights Agreement • August 3rd, 2001 • Sciclone Pharmaceuticals Inc • Pharmaceutical preparations • New York
Contract Type FiledAugust 3rd, 2001 Company Industry Jurisdiction
SCICLONE PHARMACEUTICALS, INC. 1,500,000 Shares of Common Stock, no par value PLACEMENT AGENCY AGREEMENTEscrow Agreement • November 12th, 1997 • Sciclone Pharmaceuticals Inc • Pharmaceutical preparations • New York
Contract Type FiledNovember 12th, 1997 Company Industry Jurisdiction
EXHIBIT 10.12 FIFTH AMENDMENT OF EMPLOYMENT AGREEMENT This Fifth Amendment of the Employment Agreement (this "Amendment") is entered into as of _______________, 2004 (the "Effective Date") by and between SciClone Pharmaceuticals, Inc. (the "Company")...Employment Agreement • March 15th, 2004 • Sciclone Pharmaceuticals Inc • Pharmaceutical preparations
Contract Type FiledMarch 15th, 2004 Company Industry
RECITALSSciclone Pharmaceuticals Inc • April 30th, 1999 • Pharmaceutical preparations • California
Company FiledApril 30th, 1999 Industry Jurisdiction
3 4 2. Conversion. (a) The holder of this Security is entitled at any time on or after December 7, 2001 and before the close of business on December 7, 2005 (or, in case the holder hereof has exercised his right to require the Company to repurchase...Sciclone Pharmaceuticals Inc • March 29th, 2001 • Pharmaceutical preparations
Company FiledMarch 29th, 2001 Industry
Serial Numbers of Licensed Patents: (1) U.S. Patent No. 5,366,977, issued November 22, 1994 (U.S. Patent Application Serial No. 07/952,965, filed September 29, 1992), entitled "Methods of Treating Cystic Fibrosis Using 8-Cyclopentyl-1,...Patent License Agreement • October 15th, 1996 • Sciclone Pharmaceuticals Inc • Pharmaceutical preparations • District of Columbia
Contract Type FiledOctober 15th, 1996 Company Industry Jurisdiction
ARTICLE 1 INTERPRETATIONManufacturing and Supply Agreement • March 15th, 2004 • Sciclone Pharmaceuticals Inc • Pharmaceutical preparations
Contract Type FiledMarch 15th, 2004 Company Industry
1 EXHIBIT 10.1 CONFIDENTIAL TREATMENT--EDITED COPY REGISTRATION RIGHTS AGREEMENT REGISTRATION RIGHTS AGREEMENT, dated as of February 16, 2001, by and between SciClone Pharmaceuticals, Inc., a California corporation (the "Company"), and UBS AG, London...Registration Rights Agreement • May 15th, 2001 • Sciclone Pharmaceuticals Inc • Pharmaceutical preparations • New York
Contract Type FiledMay 15th, 2001 Company Industry Jurisdiction
LICENSE, DEVELOPMENT AND SUPPLY AGREEMENT BETWEENDevelopment and Supply Agreement • April 1st, 1997 • Sciclone Pharmaceuticals Inc • Pharmaceutical preparations • California
Contract Type FiledApril 1st, 1997 Company Industry Jurisdiction
FIRST AMENDMENT TO REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • November 6th, 2001 • Sciclone Pharmaceuticals Inc • Pharmaceutical preparations
Contract Type FiledNovember 6th, 2001 Company Industry
SCICLONE PHARMACEUTICALS, INC. STOCK OPTION AGREEMENTStock Option Agreement • November 9th, 2015 • Sciclone Pharmaceuticals Inc • Pharmaceutical preparations • California
Contract Type FiledNovember 9th, 2015 Company Industry JurisdictionSciClone Pharmaceuticals, Inc. (the “Company”) has granted to the Participant named in the Notice of Grant of Stock Option (the “Grant Notice”) to which this Stock Option Agreement (the “Option Agreement”) is attached an option (the “Option”) to purchase certain shares of Stock upon the terms and conditions set forth in the Grant Notice and this Option Agreement. The Option has been granted pursuant to and shall in all respects be subject to the terms and conditions of the SciClone Pharmaceuticals, Inc. 2015 Equity Incentive Plan (the “Plan”), as amended to the Date of Grant, the provisions of which are incorporated herein by reference. By signing the Grant Notice, the Participant: (a) acknowledges receipt of, and represents that the Participant has read and is familiar with, the Grant Notice, this Option Agreement, the Plan and a prospectus for the Plan prepared in connection with the registration with the Securities and Exchange Commission of shares issuable pursuant to the Option (t
EXHIBIT 99.1 SUBSCRIPTION AGREEMENT This Subscription Agreement (the "Agreement") is made and entered into as of January 14, 2000 by and among SciClone Pharmaceuticals, Inc., a California corporation (the "Company"), and those parties listed on the...Subscription Agreement • April 25th, 2000 • Sciclone Pharmaceuticals Inc • Pharmaceutical preparations • California
Contract Type FiledApril 25th, 2000 Company Industry Jurisdiction
INDEMNITY AGREEMENTIndemnity Agreement • August 9th, 2006 • Sciclone Pharmaceuticals Inc • Pharmaceutical preparations • Delaware
Contract Type FiledAugust 9th, 2006 Company Industry JurisdictionThis Indemnity Agreement, dated as of June 2, 2006, is made by and between SciClone Pharmaceuticals, Inc., a Delaware corporation (the “Company”), and Dr. Friedhelm Blobel (the “Indemnitee”).
1 EXHIBIT 10.3 CONFIDENTIAL TREATMENT--EDITED COPY MANUFACTURING SERVICES AGREEMENT BY AND BETWEEN SCICLONE PHARMACEUTICALS INTERNATIONAL LTD.Manufacturing Services Agreement • May 15th, 2001 • Sciclone Pharmaceuticals Inc • Pharmaceutical preparations
Contract Type FiledMay 15th, 2001 Company Industry
SCICLONE PHARMACEUTICALS, INC. RESTRICTED STOCK UNITS AGREEMENTRestricted Stock Units Agreement • November 9th, 2015 • Sciclone Pharmaceuticals Inc • Pharmaceutical preparations • California
Contract Type FiledNovember 9th, 2015 Company Industry JurisdictionSciClone Pharmaceuticals, Inc. has granted to the Participant named in the Notice of Grant of Restricted Stock Units (the “Grant Notice”) to which this Restricted Stock Units Agreement (the “Agreement”) is attached an Award consisting of Restricted Stock Units (each a “Unit”) subject to the terms and conditions set forth in the Grant Notice and this Agreement. The Award has been granted pursuant to and shall in all respects be subject to the terms conditions of the SciClone Pharmaceuticals, Inc. 2015 Equity Incentive Plan (the “Plan”), as amended to the Date of Grant, the provisions of which are incorporated herein by reference. By signing the Grant Notice, the Participant: (a) acknowledges receipt of and represents that the Participant has read and is familiar with the Grant Notice, this Agreement, the Plan and a prospectus for the Plan prepared in connection with the registration with the Securities and Exchange Commission of the shares issuable pursuant to the Award (the “Plan Prosp
RECITALSControl Agreement • March 29th, 2001 • Sciclone Pharmaceuticals Inc • Pharmaceutical preparations • California
Contract Type FiledMarch 29th, 2001 Company Industry Jurisdiction
AMENDMENT NO. 1 to PREFERRED STOCK INVESTMENT AGREEMENTPreferred Stock Investment Agreement • June 24th, 1999 • Sciclone Pharmaceuticals Inc • Pharmaceutical preparations • New York
Contract Type FiledJune 24th, 1999 Company Industry Jurisdiction
RECITALSPurchase and Sale • December 2nd, 1997 • Sciclone Pharmaceuticals Inc • Pharmaceutical preparations • California
Contract Type FiledDecember 2nd, 1997 Company Industry Jurisdiction
EXHIBIT 10.11 EMPLOYMENT AGREEMENT This Employment Agreement (the "Agreement") is entered into as of February 1, 1996 between SciClone Pharmaceuticals, Inc. a California corporation, (the "Company"), and Donald R. Sellers, an individual ("Employee")....Employment Agreement • March 15th, 2004 • Sciclone Pharmaceuticals Inc • Pharmaceutical preparations • California
Contract Type FiledMarch 15th, 2004 Company Industry Jurisdiction
EXHIBIT A TO WARRANT SCICLONE PHARMACEUTICALS, INC. WARRANT EXERCISE AGREEMENTWarrant Exercise Agreement • April 25th, 2000 • Sciclone Pharmaceuticals Inc • Pharmaceutical preparations
Contract Type FiledApril 25th, 2000 Company Industry
6,900,000 Shares Common Stock ($0.001 Par Value) UNDERWRITING AGREEMENTUnderwriting Agreement • August 27th, 2003 • Sciclone Pharmaceuticals Inc • Pharmaceutical preparations • New York
Contract Type FiledAugust 27th, 2003 Company Industry JurisdictionSciClone Pharmaceuticals, Inc., a Delaware corporation (the “Company”), proposes to issue and sell to the underwriters named in Schedule A annexed hereto (the “Underwriters”), for whom you are acting as representative(s), an aggregate of 6,000,000 shares (the “Firm Shares”) of Common Stock, $0.001 par value (the “Common Stock”), of the Company. In addition, solely for the purpose of covering over-allotments, the Company proposes to grant to the Underwriters the option to purchase from the Company up to an additional 900,000 shares of Common Stock (the “Additional Shares”). The Firm Shares and the Additional Shares are hereinafter collectively sometimes referred to as the “Shares.” The Shares are described in the Prospectus which is referred to below.